Grand Pharmaceutical Group Limited (HKG:0512)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
5.30
+0.02 (0.38%)
Aug 26, 2026, 4:08 PM HKT

HKG:0512 Financials Overview

Millions HKD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
12,48312,28311,64510,5309,5628,598
Revenue Growth
1.63%5.48%10.59%10.12%11.22%35.34%
Gross Profit
6,4956,7806,7386,5245,9515,247
Operating Income
1,6961,7672,2212,8602,7482,170
Net Income
1,1091,2412,4681,8802,0792,403
Earnings Per Share
0.320.350.700.540.590.68
EPS Growth
-10.61%-49.73%31.52%-8.70%-13.31%30.14%

Revenue by Geography

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
The People's Republic of China (PRC)
10,62610,62610,0468,7227,4547,422
America
759.42759.42589.43687.45956.04430.1
Europe
432.68432.68478.29562.25566.53297.96
Asia Other than The People's Republic of China (PRC)
408.91408.91474.96512.09480.81330.89
Others
56.1656.1655.9845.87105.11116.89
Total
12,28312,28311,64510,5309,5628,598

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1,2263,9274,8033,2713,3383,504
Total Debt
5,0534,7254,4453,4074,4783,656
Net Cash (Debt)
-3,828-797.39357.94-135.89-1,139-151.9
Net Cash Growth
------
Net Cash Per Share
-1.09-0.230.10-0.04-0.32-0.04

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-1,6501,8982,4251,8432,006
Capital Expenditures
--726.15-555.78-487.73-626.22-471.57
Free Cash Flow
-923.371,3421,9371,2161,534
Free Cash Flow Growth
--31.21%-30.71%59.25%-20.71%23.03%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
52.03%55.20%57.87%61.96%62.24%61.03%
Operating Margin
13.58%14.38%19.07%27.16%28.74%25.24%
Pretax Margin
10.96%12.16%24.49%22.26%26.32%32.40%
Profit Margin
8.89%10.10%21.20%17.85%21.75%27.94%
FCF Margin
-7.52%11.53%18.40%12.72%17.84%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
0.1690.1690.2600.2600.1400.110
Dividend Per Share Growth
-35.00%-35.00%0%85.71%27.27%0%
Dividend Yield
3.21%2.23%5.86%7.26%3.58%2.06%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
14.9622.156.817.667.809.54
Forward PE
9.6811.948.117.317.909.61
P/FCF Ratio
20.1029.7712.527.4313.3414.95
PS Ratio
1.512.241.441.371.702.67